Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))

Brooke A. Schlappe, Jennifer J. Mueller, Oliver Zivanovic, Ginger J. Gardner, Kara Long Roche, Yukio Sonoda, Dennis S. Chi, Roisin E. O'Cearbhaill

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Erratum: Corrigendum to “Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center” (Gynecologic Oncology (2016) 142 (13–18)) (S009082581630734X) (10.1016/j.ygyno.2016.05.015))'. Together they form a unique fingerprint.

Medicine & Life Sciences